اختبار: العلاج بالنظائر المشعة A multiple-choice quiz consists of: 10 QuestionsQuestions are selected randomly from a collection of 17 questions. More Questions You will get deferent questions every time you take the quiz. Correct AnswersThere could be more than one correct answer, select all that apply.Skip QuestionsYou are allowed to scroll backward and forward before submitting your answers.10 MinutesThe quiz has a time limit. Time's up You can still submit your answers after the allowed period of time has ended . When ready, click Next to start the quiz. Name (Required) Email (Optional) Twitter (Optional) 1. All breastfeeding women undergoing I-131 therapy should be asked to stop breastfeeding and therapy is delayed until lactation ceases. According to the Society of Nuclear Medicine (SNM) procedure guidelines, the patient may resume breastfeeding: Never. After 6 months. After 3 months. With the birth of another child. None 2. Treatment of hyperthyroidism with antithyroid medications must be given for 6 months to 2 years, in order to be effective. The two main antithyroid drugs are: Metronidazole and Propranolol Metronidazole and Propylthiouracil Methimazole and Propranolol Methimazole and Propylthiouracil None 3. To reduce radiation exposure to the patient undergoing radioactive iodine (RAI) treatment, all of the following recommendations will be helpful EXCEPT: Patient should be well hydrated Patient should use antiperspirant medications Patient laxatives Patient should urinate frequently None 4. The general pretreatment requirements for adult qualifying for therapy with I-131 metaiodobenzylguanidine (MIBG) include the following EXCEPT: A diagnostic MIBG scan or previous posttreatment I-131 MIBG scan Blocking thyroid uptake of free radioiodine Reviewing potential interfering medications Performing pulmonary function tests None 5. The general pretreatment requirements for adult qualifying for therapy with I-131 metaiodobenzylguanidine (MIBG) include the following EXCEPT: Reviewing potential interfering medications Blocking thyroid uptake of free radioiodine A diagnostic MIBG scan or previous posttreatment I-131 MIBG scan Performing pulmonary function tests None 6. Which of the following radioisotopes approved used in the treatment of bone metastases has a significant gamma emission and can be used both for imaging and therapy? Sm-153 Sr-89 Ra-223 P-32 None 7. Samarium-153 (Quadramet) is a therapeutic radiopharmaceutical used to treat: Medullary thyroid carcinoma Pain in bony metastases Dyspnea in lung Ca Polycythemia vera None 8. What is the predominant toxicity of radioisotopes used in the treatment of bone metastases? Myelosuppression Radiation pneumonitis Gastritis Leukemia None 9. The form of targeted radionuclide therapy that uses a monoclonal antibody to deliver localized radiation is called: Radiation therapy. Antibody therapy. Radioimmunotherapy. Radiochemotherapy. None 10. The hematologic toxicity of Y-90 Zevalin therapy is common. All of the following can be a sign of hematologic toxicity EXCEPT: Bruising Arrhythmia Fever Anemia None 1 out of 10 Time's upTime is Up! بواسطة ناصر المطيري|2021-09-20T14:25:06+03:00أبريل 26th, 2021|العلاج بالنظائر المشعة|لا توجد تعليقات شارك هذه الصفحة, واترك رأيك حول الموضوع باستخدام وسيلة التواصل التي تناسبك FacebookXLinkedInWhatsAppPinterestEmail عن: ناصر المطيري كبير أخصائيي الطب النووي في مستشفى حفر الباطن المركزي و مؤسس موقع نيوكليرمد. اضف تعليقا إلغاء الردتعليق أعلمني بمتابعة التعليقات بواسطة البريد الإلكتروني. أعلمني بالمواضيع الجديدة بواسطة البريد الإلكتروني. Δ
اضف تعليقا